Cargando…

Relationship between diabetic polyneuropathy, serum visfatin, and oxidative stress biomarkers

BACKGROUND: Diabetic polyneuropathy is a very common complication of diabetes. Numerous studies are available in terms of pathogenesis. But examination methods with low reliability are still not standardized and generally time consuming. High-sensitive, easy-to-access methods are expected. Biochemic...

Descripción completa

Detalles Bibliográficos
Autores principales: Buyukaydin, Banu, Guler, Eray Metin, Karaaslan, Tahsin, Olgac, Atilla, Zorlu, Mehmet, Kiskac, Muharrem, Kocyigit, Abdurrahim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7415233/
https://www.ncbi.nlm.nih.gov/pubmed/32843933
http://dx.doi.org/10.4239/wjd.v11.i7.309
_version_ 1783569129596256256
author Buyukaydin, Banu
Guler, Eray Metin
Karaaslan, Tahsin
Olgac, Atilla
Zorlu, Mehmet
Kiskac, Muharrem
Kocyigit, Abdurrahim
author_facet Buyukaydin, Banu
Guler, Eray Metin
Karaaslan, Tahsin
Olgac, Atilla
Zorlu, Mehmet
Kiskac, Muharrem
Kocyigit, Abdurrahim
author_sort Buyukaydin, Banu
collection PubMed
description BACKGROUND: Diabetic polyneuropathy is a very common complication of diabetes. Numerous studies are available in terms of pathogenesis. But examination methods with low reliability are still not standardized and generally time consuming. High-sensitive, easy-to-access methods are expected. Biochemical markers are one of the subjects of research. We aimed to discover a potential biomarker that can be used for this purpose in patients with diabetes who have not yet developed symptoms of neuropathy. AIM: To determine the place and availability of visfatin and thiol-disulfide homeostasis in this disorder. METHODS: A total of 392 patients with type 2 diabetes mellitus were included in the study. The polyneuropathy clinical signs were evaluated with the Subjective Peripheral Neuropathy Screen Questionnaire and Michigan Neuropathy Screening Instrument questionnaire and examination. The biochemical parameters, oxidative stress markers, visfatin, and thiol-disulfide homeostasis were analyzed and correlated with each other and clinical signs. RESULTS: Subjective Peripheral Neuropathy Screen Questionnaire and Michigan Neuropathy Screening Instrument questionnaire with examination scores were correlated with each other and diabetes duration (P < 0.005). Neuropathy related symptoms were present in 20.7% of the patients, but neuropathy related findings were observed in 43.9% of the patients. Serum glucose, glycated hemoglobin, and visfatin were positively correlated with each other. Also, these parameters were positively correlated with the total oxidative stress index. Total and native thiol was positively correlated with total antioxidant status and negatively with oxidant status. Inversely thiol-disulfide positively correlated with higher glucose and oxidant status and negatively with total antioxidant status (P < 0.005). There was no correlation between visfatin and thiol-disulphide (P = 0.092, r = 0.086). However, a significant negative correlation was observed between visfatin and total with native thiol (P < 0.005, r = -0.338), (P < 0.005, r = -0.448). CONCLUSION: Diagnosis of neuropathy is one of the issues studied in patients with diabetes. Visfatin and thiol-disulfide balance were analyzed for the first time in this study with inspiring results.
format Online
Article
Text
id pubmed-7415233
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-74152332020-08-24 Relationship between diabetic polyneuropathy, serum visfatin, and oxidative stress biomarkers Buyukaydin, Banu Guler, Eray Metin Karaaslan, Tahsin Olgac, Atilla Zorlu, Mehmet Kiskac, Muharrem Kocyigit, Abdurrahim World J Diabetes Observational Study BACKGROUND: Diabetic polyneuropathy is a very common complication of diabetes. Numerous studies are available in terms of pathogenesis. But examination methods with low reliability are still not standardized and generally time consuming. High-sensitive, easy-to-access methods are expected. Biochemical markers are one of the subjects of research. We aimed to discover a potential biomarker that can be used for this purpose in patients with diabetes who have not yet developed symptoms of neuropathy. AIM: To determine the place and availability of visfatin and thiol-disulfide homeostasis in this disorder. METHODS: A total of 392 patients with type 2 diabetes mellitus were included in the study. The polyneuropathy clinical signs were evaluated with the Subjective Peripheral Neuropathy Screen Questionnaire and Michigan Neuropathy Screening Instrument questionnaire and examination. The biochemical parameters, oxidative stress markers, visfatin, and thiol-disulfide homeostasis were analyzed and correlated with each other and clinical signs. RESULTS: Subjective Peripheral Neuropathy Screen Questionnaire and Michigan Neuropathy Screening Instrument questionnaire with examination scores were correlated with each other and diabetes duration (P < 0.005). Neuropathy related symptoms were present in 20.7% of the patients, but neuropathy related findings were observed in 43.9% of the patients. Serum glucose, glycated hemoglobin, and visfatin were positively correlated with each other. Also, these parameters were positively correlated with the total oxidative stress index. Total and native thiol was positively correlated with total antioxidant status and negatively with oxidant status. Inversely thiol-disulfide positively correlated with higher glucose and oxidant status and negatively with total antioxidant status (P < 0.005). There was no correlation between visfatin and thiol-disulphide (P = 0.092, r = 0.086). However, a significant negative correlation was observed between visfatin and total with native thiol (P < 0.005, r = -0.338), (P < 0.005, r = -0.448). CONCLUSION: Diagnosis of neuropathy is one of the issues studied in patients with diabetes. Visfatin and thiol-disulfide balance were analyzed for the first time in this study with inspiring results. Baishideng Publishing Group Inc 2020-07-15 2020-07-15 /pmc/articles/PMC7415233/ /pubmed/32843933 http://dx.doi.org/10.4239/wjd.v11.i7.309 Text en ©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.
spellingShingle Observational Study
Buyukaydin, Banu
Guler, Eray Metin
Karaaslan, Tahsin
Olgac, Atilla
Zorlu, Mehmet
Kiskac, Muharrem
Kocyigit, Abdurrahim
Relationship between diabetic polyneuropathy, serum visfatin, and oxidative stress biomarkers
title Relationship between diabetic polyneuropathy, serum visfatin, and oxidative stress biomarkers
title_full Relationship between diabetic polyneuropathy, serum visfatin, and oxidative stress biomarkers
title_fullStr Relationship between diabetic polyneuropathy, serum visfatin, and oxidative stress biomarkers
title_full_unstemmed Relationship between diabetic polyneuropathy, serum visfatin, and oxidative stress biomarkers
title_short Relationship between diabetic polyneuropathy, serum visfatin, and oxidative stress biomarkers
title_sort relationship between diabetic polyneuropathy, serum visfatin, and oxidative stress biomarkers
topic Observational Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7415233/
https://www.ncbi.nlm.nih.gov/pubmed/32843933
http://dx.doi.org/10.4239/wjd.v11.i7.309
work_keys_str_mv AT buyukaydinbanu relationshipbetweendiabeticpolyneuropathyserumvisfatinandoxidativestressbiomarkers
AT gulereraymetin relationshipbetweendiabeticpolyneuropathyserumvisfatinandoxidativestressbiomarkers
AT karaaslantahsin relationshipbetweendiabeticpolyneuropathyserumvisfatinandoxidativestressbiomarkers
AT olgacatilla relationshipbetweendiabeticpolyneuropathyserumvisfatinandoxidativestressbiomarkers
AT zorlumehmet relationshipbetweendiabeticpolyneuropathyserumvisfatinandoxidativestressbiomarkers
AT kiskacmuharrem relationshipbetweendiabeticpolyneuropathyserumvisfatinandoxidativestressbiomarkers
AT kocyigitabdurrahim relationshipbetweendiabeticpolyneuropathyserumvisfatinandoxidativestressbiomarkers